Corbus Pharmaceuticals Holdings Depreciation & Amortization 2011-2026 | CRBP

Annual Depreciation & Amortization Corbus Pharmaceuticals Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
233 K	588 K	641 K	763 K	1 M	1.12 M	739 K	494 K	256 K	87.7 K	43.9 K	10.4 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.12 M	10.4 K	498 K

Quarterly Depreciation & Amortization Corbus Pharmaceuticals Holdings

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
100 K	100 K	81 K	-	200 K	200 K	152 K	-	200 K	200 K	182 K	-	191 K	192 K	196 K	-	792 K	536 K	272 K	-	202 K	320 K	319 K	-	158 K	156 K	153 K	-	132 K	124 K	81.9 K	-	127 K	33 K	31.5 K	-	20.5 K	37.2 K	17.3 K	-	14.7 K	6.12 K	5.37 K	-	5.03 K	180	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
792 K	180	158 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
ACADIA Pharmaceuticals ACAD	920 K	$ 22.42	1.49 %	$ 3.72 B	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Alnylam Pharmaceuticals ALNY	55.7 M	$ 326.77	2.27 %	$ 42.8 B	USA
Amgen AMGN	5.17 B	$ 349.41	2.77 %	$ 188 B	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 20.33	-1.21 %	$ 950 M	USA
Aquestive Therapeutics AQST	548 K	$ 4.16	0.73 %	$ 445 M	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	154 K	-	-	$ 1.41 B	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.49	5.24 %	$ 3.12 B	USA
Cabaletta Bio CABA	1.65 M	$ 3.07	-0.16 %	$ 308 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	1.48 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.48	8.46 %	$ 394 M	Britain
CTI BioPharma Corp. CTIC	1.95 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Aytu BioScience AYTU	5.38 M	$ 2.71	5.51 %	$ 17 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	4.63 M	-	-	$ 2.02 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.75	-1.32 %	$ 252 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA